Study Overview
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents
Locations
Study Overview
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents
BGB-A317-214
Recruiting
Efficacy and Safety of Tislelizumab (BGB-A317) as Neo-Adjuvant Treatment in Patients With Colorectal Cancer
Beigene Study ID
BGB-A317-214
ClinicalTrials.gov ID
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents
Sex: All
Age: 18 Years and older (Adult, Older Adult)
No Study Documents